-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's right to use underlying asset under operating lease.
-
Summary
-
ZyVersa Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q4 2023.
- ZyVersa Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $7.84K, a 92% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)